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A b s t r a c t
Introduction: Thanks to laparoscopy and enhanced recovery protocols (ERAS) it is possible to shorten hospitalization. 
Therefore, it seems reasonable to search for new early markers of infectious complications in order to select patients 
who are prone to development of complications.
Aim: To assess the usefulness of serum levels of C-reactive protein, interleukin-6 and procalcitonin as early indicators 
of infectious complications in patients after laparoscopic colorectal surgery with ERAS.
Material and methods: The prospective analysis included consecutive patients who underwent laparoscopic col-
orectal cancer resection. The following parameters were included in the analysis: C-reactive protein (CRP), interleu- 
kin 6 (IL-6) and procalcitonin measured on postoperative days (PODs) 1, 2, 3. Patients were divided into two groups: 
uncomplicated (group 1) and complicated (group 2). The difference in levels of the markers and the dynamics of 
changes observed in both groups were analyzed.
Results: Group 1 comprised 34 patients, and group 2 consisted of 17 patients. A significant increase of both absolute 
values and delta increments on all postoperative days was noted. ROC curve analysis showed that the best cut-off val-
ues indicating an infectious process were: CRP 129 mg/l on POD3 (92% sensitivity/80% specificity), IL-6 of 78 pg/ml 
on POD2 (91% sensitivity/97% specificity) and PCT 0.24 ng/ml on POD3 (93% sensitivity/68% specificity).
Conclusions: Our study showed that regular measurement of all analyzed markers in the early postoperative days 
may be beneficial in the detection of postoperative infectious complications. Further studies are needed to fully as-
sess the role of routine biochemical measurements in the postoperative period after laparoscopic surgery with the 
ERAS protocol.
Key words: complications, laparoscopy, inflammatory markers, procalcitonin, colorectal surgery, enhanced recovery 
after surgery protocol.
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Introduction 
Colorectal surgical procedures are character-
ized by a  relatively high incidence (up to 15%) of 
infectious complications [1], which can rise to 30% 
among patients undergoing surgery for cancer [2]. 
The most important factors in the reduction of infec-
tious complications, mainly surgical site infections 
(SSI), are proper, minimally invasive surgical tech-
nique and optimal perioperative care. Based on cur-
rent literature, laparoscopic procedures contribute to 
a reduction of global risk of postoperative complica-
tions [3] and the incidence of SSI [4]. In addition, the 
use of the perioperative care protocols, based on the 
Enhanced Recovery After Surgery (ERAS) guidelines, 
reduces the global postoperative complication rate 
by up to 40%, shortens length of stay (LOS) and re-
duces treatment costs [5–7]. 
However, due to reduced average LOS, the peri-
od of close supervisions is also shortened and some 
complications may develop after discharge from 
hospital, resulting in subsequent readmission [8]. In 
fact, most infections are clinically revealed 4–6 days 
after the operation, which is later than the usual LOS 
after laparoscopic surgery. Therefore, it has become 
particularly important to search for specific markers 
which can be used as surrogates for early detection 
of infectious complications and, if possible, predic-
tion of their severity during the asymptomatic pe-
riod [9]. This would allow for screening of patients 
who should either stay in the hospital longer or be 
more closely monitored after discharge.
In recent years, many studies have concentrated 
on several biochemical inflammatory markers such 
as C-reactive protein (CRP), interleukin-1 (IL-1) and 
-6 (IL-6), or procalcitonin (PCT). All of them have 
proven their clinical value in predicting infectious 
complications [10–13]. However, there are limited 
data on the use of these markers in surgical patients 
undergoing minimally invasive procedures with ad-
dition of the ERAS protocol [14, 15]. 
Aim
The aim of the study was to determine the use-
fulness of CRP, IL-6 and PCT as early indicators of in-
fectious complications among patients undergoing 
laparoscopic radical resection for colorectal cancer 
with the perioperative ERAS protocol.
Material and methods
The study was conducted in a tertiary reference 
center (university hospital). Data from patients with 
colon cancer undergoing laparoscopic radical col-
orectal resection were collected prospectively. Inclu-
sion criteria for the study were: age over 18 years, 
elective laparoscopic surgery for colorectal adeno-
carcinoma and use of the ERAS protocol in periop-
erative care. Exclusion criteria included: patients un-
dergoing open (including conversion from minimally 
invasive approach) or emergency surgery and those 
who required multivisceral resection exceeding the 
large bowel (T4), distant metastases (M1), or rectal 
cancer treated with transanal endoscopic microsur-
Table I. ERAS protocol used in our unit
 1. Preoperative counseling and patient’s education
 2.  No bowel preparation (oral lavage in the case of low 
rectal resection with total mesorectal excision (TME) 
and defunctioning loop ileostomy) 
 3.  Pre-operative carbohydrate loading (400 ml of Nutricia 
preop 2 h prior to surgery)
 4.  Antithrombotic prophylaxis (Clexane 40 mg s.c. starting 
in the evening prior to surgery)
 5.  Antibiotic prophylaxis (preoperative cefuroxime 1.5 g  
+ metronidazole 0.5 g i.v. 30–60 min prior to surgery)
 6. Laparoscopic surgery
 7.  Balanced intravenous fluid therapy (< 2500 ml  
intravenous fluids during the day of surgery, less than 
150 mmol sodium)
 8.  No nasogastric tubes postoperatively
 9.  No drains left routinely for colonic resections, one drain 
placed for < 24 h in case of TME
10.  Transversus abdominis plane (TAP) block, epidural an-
aesthesia in cases with high risk of conversion
11.  Avoiding opioids, multimodal analgesia (oral when 
possible – paracetamol 4 × 1 g, ibuprofen 2 × 200 mg, 
metamizole 2 × 2.5 g, or ketoprofen 2 × 100 mg) 
12.  Prevention of postoperative nausea and vomiting 
(PONV) (dexamethasone 8 mg i.v., ondansetron  
8 mg i.v., metoclopramide 10 mg i.v.)
13.  Postoperative oxygenation therapy (4–6 l/min)
14.  Early oral feeding (oral nutritional supplement 4 h 
postoperatively, light hospital diet and oral nutritional 
supplements on the first postoperative day, full hospital 
diet on the second postoperative day)
15.  Urinary catheter removal on the first postoperative day
16.  Full mobilization on the first postoperative day (getting 
out of bed, going to toilet, walking along the corridor,  
at least 4 h out of bed)
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gery (TEM). Also, patients with inflammatory bow-
el disease, patients with active infection (less than 
2 weeks before the procedure) and diagnosed with 
autoimmune disease and patients among whom im-
plementation of the ERAS protocol was not possible 
(i.e. due to hospitalization in ICU directly after sur-
gery) were excluded from the study. 
Laparoscopic access with four or five trocars and 
the medial to lateral approach was used as a surgi-
cal technique [16]. All patients had the same periop-
erative care based on the ERAS protocol (Table I), 
which has been used in this institution for 5 years. 
Mean compliance with the protocol is over 80% [17].
Blood samples were taken from all patients on 
the day of surgery (preoperatively) and every morn-
ing before the first meal for 3 consecutive postoper-
ative days (POD).
Serum from a blood sample (1 vial of 4.9 ml) was 
centrifuged for 10 min at 4,000 rpm and then frozen 
at –80°C until a full set of specimens was collected. 
Laboratory results for all samples included CRP, IL-6 
and PCT levels. 
Subsequently, patients were divided into two 
groups: without perioperative infectious complica-
tions (group 1) and with perioperative infectious 
complications (group 2). European Centre for Dis-
ease Prevention and Control (ECDC) guidelines were 
used for diagnosis and assessment of severity of in-
fectious complications [18].
Statistical analysis
Descriptive statistics for both groups included age, 
sex, body mass index (BMI), American Society of Anes-
thesiologists (ASA) score, type of surgery, tumor stag-
ing, operative time, intraoperative blood loss as well 
as degree of ERAS implementation. The difference in 
the concentration of measured markers between the 
groups was analyzed. The dynamics changes of each 
analyzed marker concentrations (daily increments 
analysis) on successive days were also assessed. We 
performed ROC analysis to determine the optimal 
POD for obtaining the markers and the cut-off values.
All data were analyzed with StatSoft Statistica 
v.13. The results are presented as mean ± standard 
deviation (SD), median and interquartile range (IQR). 
The study of categorical variables used the c2 test 
of independence. The Shapiro-Wilk test was used to 
check for a normal distribution of data and Student’s 
t-test was used for normally distributed quantita-
tive data. For non-normally distributed quantitative 
variables, the Mann-Whitney U  test was used. For 
dependent variables the Friedman test was used. 
A receiver operating characteristic (ROC) curve was 
applied to obtain the area under the curve (AUC) 
and determine the best cut-off values for each an-
alyzed marker. Results were considered statistically 
significant when the p-value was < 0.05. The study 
was approved by the local Ethics Review Committee 
(approval number KBET/211/B/2014). All procedures 
have been performed in accordance with the ethical 
standards laid down in the 1964 Declaration of Hel-
sinki and its later amendments (Fortaleza).
Results
One hundred and four patients underwent col-
orectal resection between August 2014 and Sep-
tember 2015. Thirty of them were excluded be-
Figure 1. Patients’ flow through the study
Patients who underwent colorectal 
resection (n = 104)
Laparoscopic colorectal resection  
for cancer (n = 74)
Included in the study after surgery  
(n = 53)
Final inclusion into analysis (n = 51)
– Without complications (n = 37)
– With complications (n = 14)
Excluded from the study before surgery 
(n = 30): 
–  Benign disease other than adeno-
carcinoma malignant tumor (n = 9) 
–  Metastatic disease (n = 8)
–  Initially open surgery (n = 6)
–  Initially multivisceral resection  
planned (n = 5)
– Inflammatory bowel disease (n = 2)
Excluded from the study during surgery 
(n = 21):
–  No primary tumor resection (bypass 
anastomosis or colostomy) (n = 5)
–  Metastases found intraoperatively 
(n = 2)
–  Local infiltration to adjacent organs 
(multivisceral resection) (n = 10)
–  Conversion (n = 4) 
Excluded from the study after surgery 
(n = 2):
–  ICU stay immediately after the 
operation (n = 2)
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fore surgery, 21 during surgery. Two patients were 
excluded because the ERAS protocol was not fully 
implemented in the postoperative period. Patients’ 
flow through the study and reasons for exclusion are 
shown in Figure 1.
Groups 1 and 2 consisted of 37 (72.5%) and 14 
(27.5%) patients, respectively. Table II shows the de-
mographic comparison of both groups and shows 
no significant differences in terms of age, sex, BMI, 
ASA scale, type of performed surgery, operative time, 
intraoperative blood loss or cancer stage. However, 
there was a  significant difference in median LOS 
(4 vs. 9 days, p < 0.001) between the groups. The analy-
sis of infectious complications is presented in Table III 
and laboratory measurements are displayed in Ta-
ble IV. Before surgery (POD0 measurement), CRP, IL-6 
and PCT levels were comparable. On POD1, levels of 
all measured markers increased in both groups. In 
all measurements during the postoperative period, 
the increase of marker levels was greater in group 2 
(Figures 2–4). This observation was applicable to 
all evaluated markers and differences between the 
groups were statistically significant (p < 0.05). 
ROC curve analysis was then performed. For 
every analyzed marker, curves for successive PODs 
were compared against each other to find the curve 
Table II. Demographic analysis of patient groups
Parameter Group 1 – not 
complicated
Group 2 – 
complicated
Statistical 
significance
Patients, n (%) 37 (72.5) 14 (27.5) –
Females, n (%) 17 (45.9) 7 (50.0) 0.79585
Males, n (%) 20 (54.1) 7 (50.0)
Age, mean ± SD [years] 67.1 ±13.7 63.9 ±10.9 0.449483
BMI, mean ± SD [kg/m2] 26.7 ±4.8 28.1 ±4.4 0.060147
ASA 2, n (%) 23 (62.2) 7 (50.0) 0.43302
ASA 3, n (%) 14 (37.8) 7 (50.0)
AJCC stage I, n (%) 18 (48.6) 7 (50.0) 0.99571
AJCC stage II, n (%) 8 (21.6) 3 (21.4)
AJCC stage III, n (%) 11 (29.8) 4 (28.6)
Right hemicolectomy, n (%) 12 (32.4) 5 (35.8) 0.87697
Left hemicolectomy, n (%) 1 (2.7) 1 (7.1)
Sigmoid resection, n (%) 10 (27.1) 3 (21.4)
Low anterior resection of the rectum, n (%) 13 (35.1) 4 (28.6)
Abdominoperineal excision, n (%) 1 (2.7) 1 (7.1)
Formation of stoma, n (%) 11 (29.7) 3 (21.4) 0.54671
Operative time, mean ± SD [min] 208 ±61.5 193 ±59.6 0.838029
Operative time, median (IQR) [min] 210 (160–240) 180 (160–260)
Intraoperative blood loss, mean ± SD [ml] 98.2 ±74.6 118.3 ±104.1 0.291479
Intraoperative blood loss, median (IQR) [ml] 50 (50–150) 85 (50–150)
Length of hospital stay, mean (range) [days] 3.9 ±1.9 (2–8) 9.6 ±6.6 0.000507
Length of hospital stay, median (IQR) [days] 4 (2–5) 9 (4–12)
Readmission, n (%) 4 (10.8) 2 (14.3) 0.73547
Compliance with ERAS protocol 85.7 ±8.6 82.8 ±8.8 0.128201
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with the best AUC parameters. Next, the cut-off 
point for the best curve was established (Figures 
5–7). The best day for measurement of CRP and PCT 
is POD3, while for IL-6 the analysis shows POD2 as 
being a more effective choice. 
In the case of PCT, the cut-off point for POD3 was 
established at 0.458 ng/l. However, the course of the 
curve indicated the presence of the second potential 
cut-off value. Further analysis of the cost-effective-
ness of ROC curves at a 10-fold higher incidence of 
non-recognition of disease than suspected patholo-
gy in healthy populations showed that a better cut-
off point would be the value of 0.244 ng/l (Figure 7). 
The same analysis was performed for the other pa-
rameters (CRP on POD3 and IL-6 on POD2), but the 
established cut-off values were similar to those pre-
viously calculated.
Finally, a comparison of all obtained curves was 
performed (Figure 8). Data showed that the best sin-
gle measurement is IL-6 on POD2.
If all three tests were jointly performed (IL-6 on 
POD2 and PCT with CRP on POD3, with established 
cut-off points), that combined test would achieve 
sensitivity of 100% and 81% specificity if two of 
those three tests were negative (Figure 9).
Discussion
This study showed that in all patients, regardless 
of complications, all parameters increased after the 
operation as compared to preoperative values. This 
rise was more pronounced among patients with in-
fectious complications. Moreover, we observed that 
among uncomplicated cases, levels of CRP, IL-6 and 
PCT – after an initial rapid increase on POD1 – re-
mained stable or even decreased over the following 
days. That dynamic was not observed among pa-
tients who developed complications. We noted that 
the most specific single marker is IL-6 measured on 
POD2. However, consecutive measurements of IL-6 
Table IV. Analysis of biochemical parameters
Parameter Group 1 – not complicated Group 2 – complicated Statistical significance
CRP, mean ± SD (median):
Pre 14.33 ±39.22 (3.30) 18.96 ±30.39 (5.70) 0.118844
1 75.65 ±36.78 (81.30) 102.71 ±50.18 (109.82) 0.039516
2 111.67 ±62.10 (109.69) 220.81 ±69.68 (250.10) 0.000006
3 88.83 ±85.08 (57.35) 230.25 ±91.60 (240.55) 0.000154
IL-6, mean ± SD (median):
Pre 23.96 ±50.91 (5.11) 17.77 ±31.42 (10.10) 0.359943
1 78.14 ±68.23 (58.34) 345.63 ±402.98 (147.00) 0.002355
2 34.34 ±22.84 (25.62) 763.49 ±1906.56 (121.80) 0.000004
3 17.99 ±11.80 (12.71) 206.26 ±332.67 (50.71) 0.000224
PCT, mean ± SD (median):
Pre 0.10 ±0.20 (0.04) 0.30 ±0.85 (0.04) 0.701681
1 0.52 ±0.71 (0.21) 1.12 ±1.49 (0.46) 0.042699
2 0.63 ±1.27 (0.20) 1.41 ±1.33 (1.27) 0.004723
3 0.68 ±2.14 (0.13) 1.24 ±1.39 (0.90) 0.001502
Table III. Types of complications
Complications N (%)
Anastomotic leakage 4 (7.8)
Surgical site infection – deep or superficial form 4 (7.8)
Intraperitoneal abscess 2 (3.9)
Urinary tract infection 2 (3.9)
Pneumonia 1 (1.9)
Infectious diarrhea (C. difficile) 1 (1.9)
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on POD2 combined with CRP and PCT on POD3 may 
give more reliable information for decision-making 
about safe discharge of patients from hospital after 
laparoscopic colorectal surgery.
The majority of previous studies which analyzed 
inflammatory markers were based on populations 
treated with a  classical surgical approach without 
the perioperative ERAS protocol [12, 14, 19]. Both 
laparoscopic surgery and the ERAS protocol have 
been shown to diminish the inflammatory response 
after surgical trauma [20–22]. It may be expected 
that the impact of the surgery itself on the inflam-
 Pre 1 2 3
Postoperative time [days]
 Group 1          Group 2
Figure 2. Mean CRP levels measured during con-
secutive PODs in both groups
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Figure 3. Mean results of IL-6 measurements on 
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Figure 4. Mean PCT levels in both groups, mea-
sured on consecutive PODs
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Figure 5. ROC curve analysis for CRP on successive PODs. AUC analysis revealed that the best parameters 
are achieved on POD3. Established cut-off point is 129 mg/l
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Figure 6. ROC curve analysis for IL-6 on successive PODs. AUC analysis showed the best parameters on 
POD2. Established cut-off point is 78.04 pg/l
ROC curves
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Youden’s Index = 0.88
Cut off point: 78.04
78.04
91% sensitivity/specificity 97%
AUC 0.97
Se
ns
it
iv
it
y
Se
ns
it
iv
it
y
1.0
0.8
0.6
0.4
0.2
0
1.0
0.8
0.6
0.4
0.2
0
 0 0.2 0.4 0.6 0.8 1.0
         1-Specificity
 PCT POD1       PCT POD2
 PCT POD3       Baseline
 0 0.2 0.4 0.6 0.8 1.0
         1-Specificity
Figure 7. ROC curve analysis for PCT on successive PODs. POD3 was observed to achieve the best parame-
ters in AUC evaluation. Established cut-off point is 0.244 ng/l (see text description)
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Figure 9. ROC curve analysis for the combined 
test based on measurements of 3 successive 
values (IL-6 on POD2 and PCT with CRP on POD3 
with previously established cut-off points). 
When 2 of the 3 values are “negative”, the test 
predicts an uncomplicated postoperative period 
with sensitivity of 100% and specificity of 81%
matory response will be minor in this case. Several 
studies have unequivocally shown that this thesis 
has been confirmed in clinical observations [20, 23–
25]. It could be expected that the concentrations, as 
well as the cut-off values, of analyzed inflammato-
ry markers will vary significantly in our population 
when compared to the classical approach. In the 
case of ultra-short postoperative stays, early de-
tection of infectious complications is crucial due to 
the short supervision of these patients. This study 
showed that inflammatory markers can be used as 
a surrogate for determining the high-risk group for 
infectious complications.
C-reactive protein is a well-studied plasma mark-
er for anastomotic leak or other infectious compli-
cations after colorectal surgery. However, similarly, 
most of the studies were based on patients operated 
on in a classical approach without the ERAS protocol, 
and the authors define a  cut-off value for postop-
erative day 4 or 5 [26–29]. Also, established cut-off 
points were designed to be as specific as possible 
in detecting specific septic complications (usually 
anastomosis leak), and are much higher than val-
ues occurring in the course of the infectious process 
without sepsis.
Our study was designed not to detect a specific 
complication, but to identify a group at high risk of 
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infectious complications in order to consider longer 
hospital stay or closer surveillance during follow-up. 
The cut-off values were established at very low lev-
els to ensure that almost no infectious complication 
was missed, accepting the fact that a  meaningful 
number of patients who will not develop infectious 
complications will still be included in the high risk 
group.
To achieve this goal we performed cost-effective-
ness analysis of ROC curves where we established 
that the “cost” of a patient missed by a test and who 
develops complications is ten times greater than the 
“cost” of a patient who is assigned to the high-risk 
group and yet does not develop any infectious com-
plications. 
Our analysis has shown that CRP level measure-
ments well differentiates patients into two groups as 
early as on POD1. Evaluation of ROC curves showed 
that the best sensitivity and specificity are achieved 
on POD3. The proposed cut-off values used in our 
research are much lower than previously mentioned 
in other studies involving open resections [27, 29], 
but are similar to those performed on laparoscopic 
groups [30, 31]. 
Only a few studies have examined the utility of 
IL-6 as a marker of anastomosis leak, SSI or other 
infectious complications in colorectal surgery [32, 
33]. This might be due to the difficulty in determin-
ing the exact value of this marker in plasma samples 
gathered from operated patients, due to a relatively 
short half-life of IL-6 [34]. Zielinska-Borkowska et al. 
did not confirm the usefulness of IL-6 in prediction 
of anastomotic leak [32]. Having said that, their 
analysis was based only on preoperative and POD1 
measurements. Moreover, the studied population 
was much more heterogeneous then the one investi-
gated in our study. Bilgin et al. analyzed IL-6 in fluid 
derived from drains on POD3 and POD5 after low 
anterior resections and did not find significant dif-
ferences between groups [33]. That analysis did not 
measure the systemic response but only local IL-6 
production. Moreover, it is obvious that the perito-
neum secretes more fluid during peritonitis, which 
could cause dilution of the analyzed marker. This 
could explain why this test did not reveal differenc-
es. Our study demonstrated the value of this mark-
er for the differentiation of uncomplicated patients 
and those who develop infectious complications. 
The levels of IL-6 significantly varied, even on POD1, 
between the two groups. The analysis based on the 
ROC curve showed that the most clinically significant 
values are obtained on POD2. It seems that, despite 
the difficulty of determining the exact value for this 
parameter and its variability across measurements, 
the differences between the analyzed groups are of 
such a large magnitude that the pre-laboratory bias 
is minimized.
Procalcitonin is considered a  very good marker 
of the systemic inflammatory response to infections, 
especially caused by Gram-negative bacteria. It is 
more specific than CRP, particularly in systemic in-
fections such as pneumonia, infectious endocarditis 
or sepsis [35]. Also, because of the shorter half-life, it 
is considered to be a more useful indicator for mon-
itoring the response to treatment in the case of an 
ongoing infection, compared to CRP. The literature 
indicates its significance in detecting anastomotic 
leaks and other SSI in colorectal surgery [36–38]. 
Our analysis confirmed this observation. Statistically 
significant differences in obtained values of procal-
citonin for both groups were seen as early as POD1 
and the analysis of ROC curves showed the greatest 
usefulness of determining this parameter on POD3. 
Our study shows that we can effectively predict 
an uncomplicated (due to infections) postoperative 
course in patients in whom IL-6 on POD2 and CRP 
and PCT on POD3 are below defined cut-off values. 
The sensitivity of combined measurements was 
100% (even if only 2 out of 3 tests were negative), 
and it may by a clinical criterion for safe early dis-
charge in patients undergoing laparoscopic colorec-
tal operations, managed perioperatively according to 
the ERAS protocol. 
Based on the above data, we have tried to estab-
lish a  preliminary diagnostic algorithm for asymp-
tomatic patients. The data suggest that measuring 
the IL-6 serum level on POD2 can help in the deci-
sion-making process regarding further hospitaliza-
tion. Only 3% of patients with a  negative IL-6 on 
POD2 are at risk of developing an infectious compli-
cation, so in the absence of symptoms, the patient 
can be safely discharged from hospital, when all oth-
er discharge criteria according to the ERAS protocol 
have been fulfilled. On the other hand, if the patient 
has a higher value than the cut-off point proposed in 
this research (even if the patient is asymptomatic), 
it would be advisable to keep the patient in the hos-
pital on POD3 and measure levels of CRP and PCT. If 
both tests are negative on POD3, the patient is safe 
to discharge. For patients with nonspecific symp-
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toms and a  positive test on POD3, the proposed 
sequence of tests may facilitate the decision to 
perform further diagnostic tests, including invasive 
procedures, or prolonging patient hospitalization for 
further observation.
Our study has certain limitations which are typi-
cal for a single-centre pilot study. The study sample 
is relatively small, especially in the group of patients 
with complications, which is a common problem in 
this type of research [13, 39]. Therefore, our analyses 
should be repeated in larger cohorts. On the other 
hand, all patients were selected cases, undergoing 
a  similar type of the minimally invasive colorectal 
procedure. The baseline characteristics of groups 
of patients with and without complications, as well 
as the adherence to the protocol, were comparable. 
That allows us to draw the conclusion that the differ-
ences are closely related to occurring complications. 
As a pilot study, it was merely aimed at analyzing the 
usefulness of those measurements in diagnostics of 
infectious complications in the early postoperative 
period, and to predict the best time for measure-
ment of each parameter. That is the reason why es-
tablished values of the cut-off points, as well as the 
sensitivity and specificity of the tests, can signifi-
cantly differ from the real optimal values. Our team 
is now conducting further research.
Conclusions
Our study showed that regular measurements 
of all analyzed markers in the early postoperative 
days may be beneficial in the detection of postop-
erative infectious complications. Although changes 
are observed early after surgery in all parameters, 
the most specific single marker is IL-6 measured on 
POD2. However, consecutive measurements of IL-6 
on POD2 combined with CRP and PCT on POD3 may 
give more reliable information and provide a useful 
tool for decision-making about safe discharge of 
patients from hospital after laparoscopic colorectal 
surgery with the ERAS protocol.
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